Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dynein Light Chain Tctex-Type 1 Modulates Orexin Signaling through Its Interaction with Orexin 1 Receptor
David Duguay, Erika Bélanger-Nelson, Valérie Mongrain, et al.
PLoS ONE (2011) Vol. 6, Iss. 10, pp. e26430-e26430
Open Access | Times Cited: 24

Showing 24 citing articles:

Orexin/hypocretin receptor signalling cascades
Jyrki P. Kukkonen, Christopher S. Leonard
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 314-331
Open Access | Times Cited: 181
Mouse models of Down syndrome: gene content and consequences
Meenal Gupta, A. Ranjitha Dhanasekaran, Katheleen Gardiner
Mammalian Genome (2016) Vol. 27, Iss. 11-12, pp. 538-555
Open Access | Times Cited: 151
Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders
Tian‐Rui Xu, Yang Yang, Richard J. Ward, et al.
Cellular Signalling (2013) Vol. 25, Iss. 12, pp. 2413-2423
Closed Access | Times Cited: 142
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012
Jyrki P. Kukkonen
AJP Cell Physiology (2012) Vol. 304, Iss. 1, pp. C2-C32
Closed Access | Times Cited: 133
Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations
Katheleen Gardiner
Drug Design Development and Therapy (2014), pp. 103-103
Open Access | Times Cited: 110
Consensus nomenclature for dyneins and associated assembly factors
Bryony Braschi, Heymut Omran, George B. Witman, et al.
The Journal of Cell Biology (2022) Vol. 221, Iss. 2
Open Access | Times Cited: 41
Regulation of a Truncated Form of Tropomyosin-Related Kinase B (TrkB) by Hsa-miR-185* in Frontal Cortex of Suicide Completers
Gilles Maussion, Jennie Yang, Volodymyr Yerko, et al.
PLoS ONE (2012) Vol. 7, Iss. 6, pp. e39301-e39301
Open Access | Times Cited: 84
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
Miles D. Thompson, Henri Xhaard, Takeshi Sakurai, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 61
Heterodimerization of human orexin receptor 1 and kappa opioid receptor promotes protein kinase A/cAMP-response element binding protein signaling via a Gαs-mediated mechanism
Jing Chen, Rumin Zhang, Xiaoyu Chen, et al.
Cellular Signalling (2015) Vol. 27, Iss. 7, pp. 1426-1438
Closed Access | Times Cited: 46
Dynein light chains 1 and 2 are auxiliary proteins of pH-sensitive Kir4.1 channels
Sun-Joo Lee, Jian Gao, Ellen J. Thompson, et al.
Journal of Biological Chemistry (2025), pp. 108393-108393
Open Access
Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics
Miles D. Thompson, Takeshi Sakurai, Innocenzo Rainero, et al.
Pharmaceuticals (2017) Vol. 10, Iss. 4, pp. 79-79
Open Access | Times Cited: 35
Heterodimerization of Mouse Orexin type 2 receptor variants and the effects on signal transduction
Chunmei Wang, Yanyou Pan, Rumin Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2013) Vol. 1843, Iss. 3, pp. 652-663
Open Access | Times Cited: 29
Orexin-A Promotes Cell Migration in Cultured Rat Astrocytes via Ca2+-Dependent PKCα and ERK1/2 Signals
Qing Shu, Zhuang‐Li Hu, Chao Huang, et al.
PLoS ONE (2014) Vol. 9, Iss. 4, pp. e95259-e95259
Open Access | Times Cited: 27
Dynorphin inhibits basal forebrain cholinergic neurons by pre‐ and postsynaptic mechanisms
Loris L. Ferrari, L. Agostinelli, Michael J. Krashes, et al.
The Journal of Physiology (2015) Vol. 594, Iss. 4, pp. 1069-1085
Open Access | Times Cited: 25
Recent progress in orexin/hypocretin physiology and pharmacology
Jyrki P. Kukkonen
BioMolecular Concepts (2012) Vol. 3, Iss. 5, pp. 447-463
Open Access | Times Cited: 19
Effects of a male meiotic driver on male and female transcriptomes in the house mouse
Anna K. Lindholm, Andreas Sutter, Sven Künzel, et al.
Proceedings of the Royal Society B Biological Sciences (2019) Vol. 286, Iss. 1915, pp. 20191927-20191927
Open Access | Times Cited: 13
On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding
Daniël Hoyer, Laura H. Jacobson
Medicine in Drug Discovery (2024) Vol. 22, pp. 100190-100190
Open Access | Times Cited: 1
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
Jyrki P. Kukkonen, Laura H. Jacobson, Daniël Hoyer, et al.
Pharmacological Reviews (2024), pp. PHARMREV-000953
Open Access | Times Cited: 1
Involvement of the Orexinergic System in Feeding
Pilar Marcos, Rafael Coveñas
Applied Sciences (2021) Vol. 12, Iss. 1, pp. 86-86
Open Access | Times Cited: 7
Cannabinoid receptor 2 expression modulates Gβ 1 γ 2 protein interaction with the activator of G protein signalling 2/dynein light chain protein Tctex-1
Marina Nagler, Lysann Palkowitsch, Sebastian Rading, et al.
Biochemical Pharmacology (2015) Vol. 99, pp. 60-72
Closed Access | Times Cited: 6
Neuronal Functions of Activators of G Protein Signaling
Man‐Kit Tse, Yung Hou Wong
Neurosignals (2012) Vol. 21, Iss. 3-4, pp. 259-271
Open Access | Times Cited: 6
The increase of α-synuclein and alterations of dynein in A53T transgenic and aging mouse
Yiqing Wang, Zhenjie Sun, Shouyun Du, et al.
Journal of Clinical Neuroscience (2021) Vol. 96, pp. 154-162
Closed Access | Times Cited: 6
revisit in 2012 Physiology of the orexinergic/hypocretinergic system: a
Jyrki P. Kukkonen
(2013)
Closed Access
Pharmacology of Orexin/Hypocretin Receptors
Jyrki P. Kukkonen
Elsevier eBooks (2019), pp. 31-68
Closed Access
Page 1

Scroll to top